Uncategorized

The Stem for Life Foundation is excited to announce the imminent release of The Healing Cell: How the Greatest Revolution in Medical History is Changing Your Life, written by Dr. Robin L. Smith (President and Trustee of Stem for Life Foundation), Msgr. Tomasz Trafny (Head of Science and Faith Department, Pontifical Council for Culture of the Vatican), and…

The conference was covered widely by the press, including stories and interviews through outlets such as CNN.com, the Wall Street Journal print and radio network, Bloomberg TV, Fox News Channel, Fox News, CBS, NPR, Catholic TV, Vatican Radio, Catholic News Agency, EWTN, and more. Media coverage promoted the conference, but also helped to explain the Church’s support for ethical research, highlighted…

The Stem for Life Foundation is classified as a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code and as a public charity under Sections 170(b)(1)(A)(vi) and 509(a)(1) of the Code. Information concerning the Stem For Life Foundation, including financial or charitable purposes, can be obtained by contacting us at 420 Lexington Avenue, Suite…

Dr. Ronald A. DePinho President, University of Texas MD Anderson Cancer Center We are in a period in history that is redefining the human experience, a period of major scientific advances that have increased life expectancy and positioned us to understand and control many diseases. The pace of progress has accelerated dramatically in recent years…

A highlight of the April 2013 Vatican Conference was the launch by The Stem for Life Foundation of one of its key initiatives to spread awareness about the power and promise of cellular therapy – The Student Ambassadors for the Cellular Age Program. The Program featured an inaugural class of 26 students representing 12 countries and 6 continents. The Stem for Life Foundation seeks to inspire…

Q&A with Neil Warma Opexa Therapeutics, Inc., is a publicly traded biotechnology company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases The Company’s leading therapy candidate, Tcelna™, is a T-cell immunotherapy that is in a Phase IIb clinical development program (the Abili-T trial) for the treatment of secondary progressive multiple sclerosis (SPMS). The Stem for Life…

Throughout the Second International Vatican Adult Stem Cell Conference, the Vatican and the Stem for Life Foundation honored individuals whose dedication and courage advanced the paradigm shift towards regenerative medicine. Such achievements were made through scientific research, business investments, and enduring treatment as patients. Pontifical Key Awards: Professor Silviu Itescu received the Key Innovator Award for his leadership and ingenuity in translational science and…

Dr. Robin Smith President of SFLF Presented With Award by President of the Vatican’s Pontifical Council for Culture At the April Vatican conference, Dr. Robin Smith, President of SFLF and Chairman and CEO of NeoStem, was presented with the Key Founder’s Award by Cardinal Gianfranco Ravasi, President of the Pontifical Council for Culture, for her work in driving forward the…

SFLF President Appointed to STOQ Foundation Board We are proud to announce that Dr. Robin L. Smith, President of the Stem for Life Foundation, has been appointed a board member of the “Science and Faith – STOQ” Foundation (Science, Theology and Ontological Quest), a non-profit organization that looks to create important dialogue between the Church and contemporary culture which is strongly shaped by scientific advancements. The…

Professor Silviu Itescu is the Chief Executive and founder of Mesoblast, an Australian publicly-listed company since 2004 and now the world’s largest regenerative medicine company. Professor Itescu has established an outstanding international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure. He is currently an active faculty member of Melbourne and Monash…